Key facts
- Prana Surgical’s last known valuation is $13.0M (Aug 2024).
- It has raised $7.0M; the latest was Early Stage VC ($1.5M) in Apr 2025.
- Notable investors include MedTech Innovator, Texas Medical Center, Johnson & Johnson JJDC, Cultivate(MD), GenHenn Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Prana Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Prana Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Prana Surgical
Developer of medical devices designed for minimally invasive surgery. The company's device is a tissue-sparing advanced electrosurgical instrument that is used to capture small nodules in the lungs that are difficult to diagnose and uses bipolar radiofrequency energy to simultaneously cut and seal, enabling physicians to minimize the risk of complications during the surgery process.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2022
- Employees
- 9
- Website
- pranasurgical.com/
- Ownership
- Privately Held (backing)
Prana Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prana Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prana Surgical in its N-PORT filings yet. We sweep new filings monthly.